Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 2,334,300 | 2,196,200 | 2,097,500 | 2,072,600 | 1,984,100 |
| Cost of Goods | 289,400 | 261,800 | 245,800 | 247,400 | 236,500 |
| Gross Profit | 2,044,900 | 1,934,400 | 1,851,700 | 1,825,200 | 1,747,600 |
| Operating Expenses | 918,600 | 828,900 | 811,600 | 947,900 | 693,600 |
| Operating Income | 1,126,700 | 1,106,300 | 1,040,900 | 877,700 | 1,054,500 |
| Interest Expense | 13,700 | 14,600 | 14,900 | 15,100 | 15,200 |
| Other Income | 63,400 | -67,300 | -71,200 | 8,300 | 43,500 |
| Pre-tax Income | 1,176,400 | 1,024,400 | 954,800 | 870,900 | 1,082,800 |
| Income Tax | 245,900 | 213,900 | 192,700 | 100,800 | 230,900 |
| Net Income Continuous | 930,500 | 810,500 | 762,100 | 770,100 | 851,900 |
| Net Income | $930,500 | $810,500 | $762,100 | $770,100 | $851,900 |
| EPS Basic Total Ops | 3.63 | 3.17 | 2.99 | 3.01 | 3.30 |
| EPS Basic Continuous Ops | 3.63 | 3.17 | 2.99 | 3.01 | 3.30 |
| EPS Diluted Total Ops | 3.59 | 3.13 | 2.96 | 2.98 | 3.28 |
| EPS Diluted Continuous Ops | 3.59 | 3.13 | 2.96 | 2.98 | 3.28 |
| EPS Diluted Before Non-Recurring Items | 3.62 | 3.25 | 3.16 | N/A | N/A |
| EBITDA(a) | $1,163,400 | $1,143,600 | $1,076,800 | $911,500 | $1,086,200 |